Board of Directors
Damian Marron – Chairman of the Board
-
Former CEO of Agalimmune, Trophos, TxCell
-
Highly experienced leader with strong value creation track record
-
Board Chair, Director and Advisor to several biotech companies
Frederic Garzoni – CEO/Co-founder
-
Biochemist with over 10 years of experience in leading and managing R&D project and high-tech platforms
-
BBSRC Future Talent and Mobility Award, SynBICITE 4-day MBA Award, Launch GW Award
Prof. Imre Berger – Scientific Advisor/Co-founder
-
Founding Director, Max Plank Bristol Center, Bristol Synthetic Biology Center BrisSynBio, Wellcome Trust Investigator
-
Author of over 120 papers in leading journal and international patents
-
Co-founded Geneva Biotech SARL and Redbiotec AG (exit to Pfizer)
Jackie Turnbull – Commercial Lead
-
Highly experienced Business Development and Commercial Director
-
Track record in start-ups, big pharma and consultancy
-
Board Director and Advisor to several biotech start-up companies
Luke Hakes
-
17 years of life science R&D, strategy and commercial expertise including Public Health England
-
Project management of oncology and infectious disease programmes (toxicology, CMC, regulatory, CTA preparation)
-
Senior Biotech Investment manager / Scientific Analyst
Harry Destecroix
-
Awaiting text
-
Awaiting text
-
Awaiting text